medigraphic.com
ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa

2020, Number 2

<< Back Next >>

Rev Med UAS 2020; 10 (2)

Actinomycete mycetoma, a clinical case

Rochín-Tolosa M, Rubio-Rodríguez MZ, Rodríguez-Gutiérrez JS, Muñoz-Estrada VF

Language: Spanish
References: 15
Page: 89-94
PDF size: 130.03 Kb.


ABSTRACT

Mycetoma is a chronic infectious disease of the subcutaneous tissue and skin, caused by bacteria or fungus. Mycetoma is endemic in tropical regions, it is most common in men aged 30-40 years, with a predilection for farmers. The clinical presentation is subcutaneous swelling, anatomic deformity and fistulae that drain filamentous exudate with a presence of “grains”. The causative agent and diagnosis is determined by direct analysis and secretion culture. Authors report a case in a 54-year-old agricultural worker from Sinaloa with no relevant history who is diagnosed with actinomycetoma. The patient had an adequate response to 4 months of treatment with amoxicillin, clavulanic acid and diaminophenylsulfone. This case study describes a classical clinical presentation taking into consideration how important it is to have extensive knowledge of this condition to avoid its long-lasting, devastating complications.


REFERENCES

  1. López-Martínez R, Méndez-Tovar LJ, BonifazA, Arenas R, Mayorga J, Welsh O, et al. Actualizaciónde la epidemiología del micetomaen México. Revisión de 3,933 casos. Gac MedMex. 2013;149(5):586-92.

  2. Mansilla-Lory J, Contreras-López EA. Mycetomain prehispanic Mexico. Review in theskeletical collection of Tlatilco culture. RevMed Inst Mex Seguro Soc. 2009;47(3):237-42.

  3. Relhan V, Mahajan K, Agarwal P, Garg VK.Mycetoma: an update. Indian J Dermatol.2017;62(4):332.

  4. Bonifaz A, Tirado-Sánchez A, Calderón L,Saúl A, Araiza J, Hernández M, et al. Mycetoma:experience of 482 cases in a single centerin México. PLoS Negl Trop Dis.2014;8(8):e3102.

  5. Welsh O, Vera-Cabrera L, Salinas-CarmonaMC. Mycetoma. Clin Dermatol.2007;25(2):195-202.

  6. Ahmed AA, van de Sande W, Fahal AH. Mycetomalaboratory diagnosis. PLoS Negl TropDis. 2017;11(8):e0005638.

  7. Al􀇦Hatmi AM, Bonifaz A, Tirado􀇦Sánchez A,Meis JF, de Hoog GS, Ahmed SA. Fusariumspecies causing eumycetoma: Report of twocases and comprehensive review of the literature.Mycoses. 2017;60(3):204-12.

  8. Arenas-Guzmán R. Micetoma. Micología: médicailustrada: Mc Graw Hill; 2008. p. 137-59.

  9. Muñoz-Estrada VF, García-Rodríguez MI, Mayorga-Rodríguez J, Barba-Rubio J. Micetomas:estudio epidemiológico de 13 años en eloccidente de México (1981-1993). Dermatolrev mex. 1995;39(1):13-7.

  10. Nenoff P, Van de Sande W, Fahal A, Reinel D,Schöfer H. Eumycetoma and actinomycetoma–an update on causative agents, epidemiology,pathogenesis, diagnostics andtherapy. J Eur Acad Dermatol Venereol.2015;29(10):1873-83.

  11. Verma P, Jha A. Mycetoma: reviewing a neglecteddisease. Clin Exp Dermatol.2019;44(2):123-9.

  12. Van de Sande WW. Global burden of humanmycetoma: a systematic review and metaanalysis.PLoS Negl Trop Dis.2013;7(11):e2550.

  13. Villa-Escobar AM, Cardona-Castro N. Micetoma.CES Medicina. 2008;22(1):8.

  14. Zijlstra EE, Van De Sande WW, Welsh O,Goodfellow M, Fahal AH. Mycetoma: a uniqueneglected tropical disease. Lancet Infect Dis.2016;16(1):100-12.

  15. El-Bagi MEA, Fahal AH. Mycetoma revisited.Incidence of various radiographic signs. SaudiMed J. 2009;30(4):529-33.




2020     |     www.medigraphic.com